新型心腔内超声导管与超声系统的多中心随机对照试验:INTELICE试验方案
INTELICE是一项前瞻性、多中心、随机、开放标签、非劣效性临床试验,采用盲法结局评估,比较新型Arch Echo™心腔内超声导管系统与ACUSON AcuNav导管联合P500超声系统的成像质量与安全性。主要终点为独立核心实验室超声技师用预定义1-5评分系统评估的ICE图像质量,次要终点包括术者评估图像质量、手术成功、导管到位、手术时长及安全性。
要点
- INTELICE为多中心随机开放标签非劣效性试验,比较新型与商用ICE系统的图像质量与安全性
- 主要终点为盲法核心实验室技师用1-5评分系统评估的ICE图像质量
- 试验旨在建立ICE图像质量评估标准化标准并比较术者与技师评估差异
核心结论
- INTELICE试验将为新型ICE导管系统与成熟商用设备在图像性能和手术安全性方面提供高质量对比证据。
- 研究还将建立ICE图像质量评估的标准化标准,并探索术者评估与超声技师评估之间的差异。
研究设计与样本
- 前瞻性、多中心、随机、开放标签、非劣效性临床试验,采用盲法结局评估。
- 纳入需ICE引导接受心脏介入手术的成年患者,按1:1随机分配至Arch Echo™ ICE导管系统组或ACUSON AcuNav导管联合P500超声系统组。
- 所有参与中心采用标准化ICE成像方案。
关键数值与推荐
- 主要终点为ICE图像质量,由对设备分配设盲的独立核心实验室超声技师使用预定义1-5评分系统评估。
- 次要终点包括术者评估的图像质量、手术成功、导管输送至目标位置、手术时长及安全性结局。
临床怎么用
- 若达到非劣效性,新型Arch Echo™ ICE导管系统可作为现有商用ICE系统的替代选择用于ICE引导的心脏介入手术。
- 研究建立的标准化ICE图像质量评估标准可能提高ICE引导心脏介入手术的一致性和可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracardiac echocardiography (ICE) plays an increasingly important role in guiding cardiac interventional procedures. However, evidence from randomized studies comparing different ICE catheter systems is limited, and standardized criteria for ICE image quality assessment are lacking. The INTELICE trial is designed to evaluate the efficacy and safety of a novel Arch Echo™ intracardiac ultrasound catheter and ultrasound system compared with a commercially available ICE system. METHODS: INTELICE is a prospective, multicenter, randomized, open-label, non-inferiority clinical trial with blinded outcome evaluation. Adult patients undergoing cardiac interventional procedures requiring ICE guidance are eligible for enrollment. Participants are randomized in a 1:1 ratio to receive either the Arch Echo™ ICE catheter with its dedicated ultrasound system or the ACUSON AcuNav catheter paired with the P500 ultrasound system. A standardized ICE imaging protocol is applied across all participating centers. The primary endpoint is ICE image quality, assessed using a predefined 1-5 scoring system by independent core-laboratory sonographers who are blinded to device allocation. Secondary endpoints include operator-assessed image quality, procedural success, catheter delivery to target positions, procedure duration, and safety outcomes. DISCUSSION: The INTELICE trial will provide high-quality comparative evidence on ICE image performance and procedural safety between a novel ICE catheter system and an established commercial device. In addition, this study aims to establish standardized criteria for ICE image quality assessment and to explore differences between operator-based and sonographer-based evaluations, which may improve the consistency and reliability of ICE-guided cardiac interventions. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT06344494.
引用
- Han K, Sang C, Sun M, et al. The cardiac intervention imaging clinical trial of an intracardiac ultrasound catheter and ultrasound system: the multicenter, randomized, INTELICE trial protocol. Trials. 2026. PMID: 42958556. doi:10.1186/s13063-026-09845-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。